Inhibition of Mammalian Glycoprotein YKL-40

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m116.764985
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Serum YKL-40 and Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
1999English

Bruselloz Hastalarında Serum YKL-40 Düzeylerinin Belirlenmesi

Turkish Journal of Clinics and Laboratory
2019English

Genetic and Epigenetic Regulation of YKL-40 in Childhood

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

YKL-40 - An Emerging Biomarker in Cardiovascular Disease and Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2009English

Serum YKL-40 and Interleukin 6 Levels in Hodgkin Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Cerebrospinal Fluid Neurogranin and YKL-40 as Biomarkers of Alzheimer's Disease

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2015English

YKL-40/CHI3L1 Drives Inflammation on the Road of Tumor Progression

Journal of Leukocyte Biology
AllergyImmunologyCell Biology
2015English

Interaction and Inhibition of Dengue Envelope Glycoprotein With Mammalian Receptor DC-Sign, an In-Silico Approach

PLoS ONE
Multidisciplinary
2013English

YKL-39 (Chitinase 3-Like Protein 2), but Not YKL-40 (Chitinase 3-Like Protein 1), Is Up Regulated in Osteoarthritic Chondrocytes

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy